← Back to Search

Computer-Aided Detection

CADe Colonoscopy for Colorectal Cancer (COLOWISE Trial)

N/A
Recruiting
Research Sponsored by NEC Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the procedure/surgery
Awards & highlights

COLOWISE Trial Summary

This trial will test a new device called WISE VISION® Endoscopy System during colonoscopies for colorectal cancer screening. Patients will be randomly assigned to two groups: one group will have

Who is the study for?
This trial is for individuals going to the endoscopy unit for colon cancer screening or surveillance. Participants must sign an informed consent form, indicating they understand and agree to the study's procedures.Check my eligibility
What is being tested?
The trial is testing a new Computer Aided Detection (CADe) system called WISE VISION® during colonoscopies. Patients are randomly placed into two groups: one receives a colonoscopy with CADe, while the other undergoes a standard procedure without it.See study design
What are the potential side effects?
Since this trial involves using a detection device during a standard procedure rather than medication, typical side effects related to drugs aren't expected. However, usual risks of discomfort or complications from any colonoscopy may still apply.

COLOWISE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the procedure/surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the procedure/surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adenomas per Colonoscopy (APC)

COLOWISE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CADe ColonoscopyExperimental Treatment1 Intervention
CADe Colonoscopy: Patient undergoes WISE VISION® Endoscopy CADe colonoscopy
Group II: HDWL ColonoscopyActive Control1 Intervention
HDWL Colonoscopy: Patient undergoes HDWL colonoscopy without CADe

Find a Location

Who is running the clinical trial?

Meditrial USA Inc.UNKNOWN
6 Previous Clinical Trials
1,533 Total Patients Enrolled
NEC CorporationLead Sponsor
Meditrial Europe Ltd.Industry Sponsor
20 Previous Clinical Trials
3,031 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limit that would exclude individuals younger than 35 from participating in this research study?

"For this clinical study, individuals must be at least 45 years old but no older than 75 years to qualify for participation."

Answered by AI

Are potential candidates still eligible to participate in this ongoing clinical trial?

"According to the information available on clinicaltrials.gov, this research endeavor is actively seeking eligible participants. The trial was initially listed on April 30th, 2023 and underwent its most recent update on March 19th, 2024."

Answered by AI

What is the current capacity for patient enrollment in this clinical trial?

"Indeed, the details on clinicaltrials.gov highlight that this study is currently in need of volunteers. This research initiative was initially shared on April 30th, 2023 and underwent its latest update on March 19th, 2024. The trial aims to recruit a total of 830 individuals distributed across five distinct sites."

Answered by AI

Which individuals meet the criteria for participation in this research project?

"Individuals eligible for participation in this trial must have colon adenomas and fall within the age bracket of 45 to 75 years. Enrollment aims to reach a total of 830 participants."

Answered by AI

In how many distinct clinics is this experimental investigation currently being conducted?

"The current operation of this research study spans 5 different sites. These include cities such as Portsmouth, Castellanza, and Milan among others. Opting for the nearest site to your location can reduce travel commitments when participating in the trial."

Answered by AI
~332 spots leftby Dec 2024